Document Detail

Effects of siRNA-targeting BMP-2 on the abilities of migration and invasion of human liver cancer SMMC7721 cells and its mechanism.
MedLine Citation:
PMID:  20885449     Owner:  NLM     Status:  In-Process    
To observe the effects of small interfering RNA (siRNA)-targeting bone morphogenetic protein (BMP)-2 on the abilities of migration and invasion of human liver cancer SMMC7721 cells and its mechanism. Three siRNAs-targeting BMP-2 gene were synthesized. There were six groups including group I (non-transfected cells), group II (only liposome-transfected cells), group III (non-specific siRNA-transfected cells) and groups IV-VI (siRNA-A, siRNA-B and siRNA-C-targeting BMP-2 transfected cells, respectively). SMMC7721 cells were instantaneously transfected using lipofectamine method. The levels of mRNA and protein of BMP-2 in cells were determined with reverse transcription-PCR and western blotting. The abilities of migration and invasion of transfected cells were assessed using scratch test and in vitro invasion assay, respectively. The protein levels of p-ERK, p-JNK and p-p38 and the protein levels of MMP-2 and MMP-9 were evaluated with western blot 48 h after siRNA-B-targeting BMP-2 was transfected into liver cancer SMMC7721 cells. Expression of mRNA and protein of BMP-2 in groups IV-VI were significantly inhibited, especially in group V. Cell scratch width was significantly greater in group V than in group I and III (P<0.01). In vitro invasion assay suggested that the number of invasion of cells was significantly lower in group V than in group I and III (P<0.05). Western blot indicated that the level of p-ERK was significantly decreased (P<0.05), the levels of p-JHK and p-p38 were not significantly changed and the levels of MMP-2 and MMP-9 were significantly downregulated (P<0.05). siRNA-targeting BMP-2 can markedly inhibited the expression of BMP-2 in liver cancer SMMC7721 cells, and decrease the abilities of migration and invasion of liver cancer cells, especially siRNA-B. The inhibitory effects of siRNA-B-targeting BMP-2 on the abilities of migration and invasion of human liver cancer SMMC7721 cells may be caused by the downregulation of MMP-2 and MMP-9 through MAPK/ERK pathway, whereas is not related to MAPK/JNK and MAPK/p38 pathway.
J-B Wu; H-Q Fu; L-Z Huang; A-W Liu; J-X Zhang
Related Documents :
10732719 - A threshold level of gag expression is required for particle formation in rat cells tra...
19421429 - Antitumoral effect of il-12 gene transfected via liposomes into b16f0 cells.
16896819 - Optimizing vector application for gene transfer into human hepatoblastoma cells.
9573369 - Cos cell expression studies of p86l, p86r, p480l and p480q hunter's disease-causing mut...
8890159 - Underexpression of the 43 kda inositol polyphosphate 5-phosphatase is associated with c...
10962439 - Reduced cell migration, tumor growth and experimental metastasis of rat f-11 cells whos...
10894129 - Preferential destruction of cerebellar purkinje cells by ox7-saporin.
15987639 - Sphingosine-1-phosphate induces a pdgfr-dependent cell detachment via inhibiting beta1 ...
20680269 - Therapy of thyroid carcinoma with the histone deacetylase inhibitor ms-275.
Publication Detail:
Type:  Journal Article     Date:  2010-10-01
Journal Detail:
Title:  Cancer gene therapy     Volume:  18     ISSN:  1476-5500     ISO Abbreviation:  Cancer Gene Ther.     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2010-12-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9432230     Medline TA:  Cancer Gene Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  20-5     Citation Subset:  IM    
Department of Oncology, Second Affiliated Hospital, Nanchang University, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Gene therapy with interleukin-10 receptor and interleukin-12 induces a protective interferon-?-depen...
Next Document:  Highly potent and specific siRNAs against E6 or E7 genes of HPV16- or HPV18-infected cervical cancer...